GU Oncology

Bladder Cancer

View All

Medical professionals Dr. Raji Shameem, Dr. David H. Aggen, Dr. Alexandra Drakaki, and Dr. Ashish M. Kamat discuss personalized perioperative treatment for MIBC with NIAGARA and EV-based regimens.

Bladder Cancer

07/31/2026

Ep. 4: Personalizing Perioperative Treatment for Muscle-Invasive Bladder Cancer With NIAGARA and EV-Based Regimens

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Medical professionals discussing perioperative therapy for MIBC based on patient and tumor characteristics in a hospital setting.

Bladder Cancer

07/30/2026

Ep. 3: Selecting Perioperative Therapy for Muscle-Invasive Bladder Cancer Based on Patient and Tumor Characteristics

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Medical professionals discussing perioperative MIBC interpreting pCR, survival, and treatment options in a hospital setting.

Bladder Cancer

07/26/2026

Ep. 2: Perioperative Muscle-Invasive Bladder Cancer: Interpreting pCR, Survival, and Treatment Selection

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Panel discussion on NIAGARA and EV-Based Perioperative Therapy Reshaping MIBC Treatment with Dr. Raji Shameem, Dr. David H. Aggen, Dr. Alexandra Drakaki, and Dr. Ashish M. Kamat.

Bladder Cancer

07/24/2026

Ep. 1: NIAGARA and EV-Based Perioperative Therapy Reshape Treatment for Muscle-Invasive Bladder Cancer

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Medical professionals discussing redefining perioperative bladder cancer treatment with NIAGARA in the EV + IO era.

Bladder Cancer

07/23/2026

Experts Review Perioperative Regimens and Potential Future Strategies for Resectable MIBC

Ashish M. Kamat, MD, MBBS, FACSDavid H. Aggen, MD, PhDAlexandra Drakaki, MD, PhDRaji Shameem, MD

Panel of medical experts discussing immunotherapy, bladder cancer, and multidisciplinary care for non-muscle invasive bladder cancer (NMIBC).

Bladder Cancer

06/11/2026

Real-World Integration, Immune Toxicity, and the Future of Multidisciplinary NMIBC Care

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD

Medical panel discussing Potomac trial results on Durvalumab and BCG therapy improving recurrence-free survival in cancer patients.

Bladder Cancer

06/09/2026

POTOMAC Trial Breakthrough: Durvalumab Plus BCG Shows Improved Recurrence-Free Survival

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD

Key oncology trial highlights Durvalumab and BCG combination improving disease-free survival, featuring experts Dr. Shilpa Gupta, Dr. Neal Shore, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Amit Patel.

Bladder Cancer

06/09/2026

POTOMAC Trial Breakthrough: Durvalumab Plus BCG Shows Improved Disease-Free Survival

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD

Panel discussion on high-risk non-muscle invasive bladder cancer (NMIBC) and BCG treatment limits featuring Dr. Shilpa Gupta, Dr. Neal Shore, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Amit Patel.

Bladder Cancer

06/08/2026

Defining High-Risk Non–Muscle-Invasive Bladder Cancer and the Limits of BCG Alone

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD

Panel of oncology experts discussing the integration of Durvalumab into non-muscle invasive bladder cancer (NMIBC) treatment strategies.

Bladder Cancer

06/04/2026

Clinical Insights: Integrating Durvalumab Into Non–Muscle-Invasive Bladder Cancer Care

Shilpa Gupta, MDAmit Patel, MDNeal Shore, MD, FACSRahul Gosain, MD, MBARohit Gosain, MD

Advanced multidisciplinary approaches to emerging bladder cancer treatments featuring leading experts Dr. Matt Galsky, Dr. Sia Daneshmand, Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Chad Reichard, and Dr.

Bladder Cancer

03/15/2026

Ep. 4: Multidisciplinary Approaches to Emerging Bladder Cancer Treatments

Rahul Gosain, MD, MBARohit Gosain, MDMatt Galsky, MDSia Daneshmand, MDChad Reichard, MDShilpa Gupta, MD

Advanced medical team discussing innovative approaches to perioperative ADC and immunotherapy in muscle-invasive bladder cancer.

Bladder Cancer

03/14/2026

Ep. 3: Optimizing Perioperative ADC and Immunotherapy in Muscle-Invasive Bladder Cancer

Rahul Gosain, MD, MBARohit Gosain, MDMatt Galsky, MDSia Daneshmand, MDChad Reichard, MDShilpa Gupta, MD

Advanced cancer specialists discussing systemic therapy and radical cystectomy in MIBC at OncUpdates conference. Expert panel includes Dr. Matt Galsky, Dr. Sia Daneshmand, Dr. Chad Reichard, Dr. Shilp.

Bladder Cancer

03/12/2026

Ep. 2: Coordinating Systemic Therapy and Radical Cystectomy in Muscle-Invasive Bladder Cancer

Rahul Gosain, MD, MBARohit Gosain, MDMatt Galsky, MDSia Daneshmand, MDChad Reichard, MDShilpa Gupta, MD

Shifting the Treatment Landscape in MIBC with Expert Oncologists and Innovative Approaches for Bladder Cancer Management.

Bladder Cancer

03/11/2026

Ep. 1: NIAGARA: Shifting the Treatment Landscape in Muscle-Invasive Bladder Cancer

Rahul Gosain, MD, MBARohit Gosain, MDMatt Galsky, MDShilpa Gupta, MDSia Daneshmand, MDChad Reichard, MD

Expert panel discussing evolving clinical insights in bladder cancer with Dr. Shilpa Gupta, Dr. Chad Reichard, Dr. Sia Daneshmand, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Matt Galsky.

Bladder Cancer

03/09/2026

Clinical Insights: Evolving Landscapes in MIBC and NMIBC

Rahul Gosain, MD, MBARohit Gosain, MDShilpa Gupta, MDChad Reichard, MDSia Daneshmand, MDMatt Galsky, MD

Expert panel discussion on cancer research and oncology advancements at OncUpdates.

Bladder Cancer

06/16/2025

EP. 6: Practice-Changing Insights From the NIAGARA Trial

Petros Grivas, MD, PhD

Discussion panel on oncology research at OncUpdates, featuring medical experts sharing insights on cancer treatment advancements and latest breakthroughs in oncology.

Bladder Cancer

06/16/2025

Ep. 5: NIAGARA Trial: Perioperative Durvalumab Enhances DFS in MIBC

Joshua Meeks, MD, PhD

Expert panel discussion on oncology research and recent advancements in cancer treatment.

Bladder Cancer

06/16/2025

Ep. 4: The Oncologist’s Role in Counseling Patients With MIBC Through Complex Treatment Decisions

Karine Tawagi, MD

High-level discussion on oncology research and cancer treatment advancements at OncUpdates conference. Experts share insights on innovative therapies and patient care strategies.

Bladder Cancer

06/16/2025

Ep. 3: Key Takeaways From the NIAGARA Trial for Patients With MIBC

Neal Shore, MD, FACS

In-depth interview with medical experts discussing latest advancements in cancer treatment and research, focusing on patient care, innovative therapies, and clinical trial updates.

Bladder Cancer

06/16/2025

Ep. 1: Current Treatment Strategies for Muscle-Invasive Bladder Cancer

Karine Tawagi, MD

Lecture on cancer treatment innovations discussed among medical professionals.

Bladder Cancer

06/16/2025

Ep. 2: Clinical Implications of Circulating Tumor DNA in MIBC

Petros Grivas, MD, PhDJoshua Meeks, MD, PhD

1. Expert oncologists presenting research on NIAGARA trial and perioperative durvalumab treatment for MIBC.

Bladder Cancer

06/14/2025

NIAGARA Trial: Perioperative Durvalumab for MIBC (Full Video)

Joshua Meeks, MD, PhDKarine Tawagi, MDNeal Shore, MD, FACSPetros Grivas, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD

RCC

View All

Optimizing Sequential Therapy in Advanced RCC with expert team including Dr. David Braun, Dr. Ulka Vaishampayan, Dr. Bradley McGregor, Dr. Rohit Gosain, and Dr. Rahul Gosain for oncology research and treatment advancements.

RCC

12/11/2025

Ep. 5: Optimizing Sequential Therapy in Advanced RCC

Bradley McGregor, MDUlka Vaishampayan, MBBSDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD

Second-line RCC management, tolerability, comorbidities, long-term planning expert panel discussion at OncUpdates. Featuring Dr. Bradley McGregor, Dr. David Braun, Dr. Ulka Vaishampayan, Dr. Rohit Gosain, and Dr. Rahul Gosain.

RCC

12/10/2025

Ep. 4: Second-Line RCC Management: Tolerability, Comorbidities, and Long-Term Planning

Ulka Vaishampayan, MBBSBradley McGregor, MDDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD

1. OncUpdates panel discussion on balancing patient goals and efficacy in second-line RCC therapy featuring leading oncologists.

RCC

12/09/2025

Ep. 3: Balancing Patient Goals and Efficacy in Second-Line RCC Therapy

David Braun, MD, PhDUlka Vaishampayan, MBBSBradley McGregor, MDRahul Gosain, MD, MBARohit Gosain, MD

VEGF TKIs in RCC research panel featuring Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. David Braun, and Dr. Bradley McGregor discussing toxicity and tolerability in renal cell carcinoma therapies.

RCC

12/08/2025

Ep. 2: VEGF TKIs in RCC: Toxicity and Tolerability

David Braun, MD, PhDBradley McGregor, MDRahul Gosain, MD, MBARohit Gosain, MD

RCC

12/07/2025

Ep. 1: Positioning Tivozanib in Today’s RCC Treatment Landscape

Ulka Vaishampayan, MBBSDavid Braun, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD

1. OncUpdates panel discussion on treating advanced renal cell carcinoma (RCC) after first-line therapy with leading oncologists.

RCC

12/06/2025

Treating Advanced RCC After First-Line Therapy (Full Video)

David Braun, MD, PhDBradley McGregor, MDUlka Vaishampayan, MBBSRahul Gosain, MD, MBARohit Gosain, MD